lobenzarit has been researched along with Rheumatoid Arthritis in 12 studies
lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicenter double-blind study was carried out in patients with rheumatoid arthritis (RA) by comparing treatment with a novel immunomodulator, lobenzarit, disodium 4-chloro-2, 2'-iminodibenzoate, with an inert placebo." | 9.05 | A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. ( Abe, C; Honma, M; Horiuchi, Y; Kageyama, T; Mizushima, Y; Ofuji, T; Ogawa, N; Shichikawa, K; Shiokawa, Y; Yoshizawa, H, 1984) |
| "Nephrogenic diabetes insipidus (NDI) occurred in a 43-year-old woman who had received lobenzarit disodium for the treatment of rheumatoid arthritis (RA)." | 8.79 | Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis. ( Kondo, M; Miyazaki, R; Sakane, N; Umekawa, T; Yoshida, T, 1996) |
| "A multicenter double-blind study was carried out in patients with rheumatoid arthritis (RA) by comparing treatment with a novel immunomodulator, lobenzarit, disodium 4-chloro-2, 2'-iminodibenzoate, with an inert placebo." | 5.05 | A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. ( Abe, C; Honma, M; Horiuchi, Y; Kageyama, T; Mizushima, Y; Ofuji, T; Ogawa, N; Shichikawa, K; Shiokawa, Y; Yoshizawa, H, 1984) |
| "Nephrogenic diabetes insipidus (NDI) occurred in a 43-year-old woman who had received lobenzarit disodium for the treatment of rheumatoid arthritis (RA)." | 4.79 | Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis. ( Kondo, M; Miyazaki, R; Sakane, N; Umekawa, T; Yoshida, T, 1996) |
| "Lobenzarit (disodium 4-chloro-2,2'-iminodibenzoate [CCA]) is a novel disease-modifying drug for the treatment of rheumatoid arthritis (RA)." | 3.68 | Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug. ( Hirohata, S; Inoue, T; Lipsky, PE; Miyamoto, T; Shinohara, S, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, K | 1 |
| Saitoh, F | 1 |
| Kumagai, K | 1 |
| Kosaka, S | 1 |
| Ohara, M | 1 |
| Igarashi, S | 1 |
| Kobashi, C | 1 |
| Nanamiya, M | 1 |
| Yoshida, H | 1 |
| Kasukawa, R | 1 |
| Shiokawa, Y | 1 |
| Horiuchi, Y | 1 |
| Mizushima, Y | 1 |
| Kageyama, T | 1 |
| Shichikawa, K | 1 |
| Ofuji, T | 1 |
| Honma, M | 1 |
| Yoshizawa, H | 1 |
| Abe, C | 1 |
| Ogawa, N | 1 |
| Sonozaki, H | 1 |
| Mitsui, H | 1 |
| Minami, M | 1 |
| Kaneda, K | 1 |
| Sakane, N | 1 |
| Yoshida, T | 1 |
| Umekawa, T | 1 |
| Miyazaki, R | 1 |
| Kondo, M | 1 |
| Nakano, M | 1 |
| Nishi, S | 1 |
| Ueno, M | 1 |
| Saito, T | 1 |
| Hasegawa, H | 1 |
| Arakawa, M | 1 |
| Nishinarita, S | 1 |
| Hayakawa, J | 1 |
| Suzuki, R | 1 |
| Hayama, T | 1 |
| Hiranuma, M | 1 |
| Sawada, S | 1 |
| Horie, T | 1 |
| Nishioka, K | 1 |
| Azuma, T | 1 |
| Iwasaki, Y | 1 |
| Ichinohe, T | 1 |
| Kuwahara, T | 1 |
| Yata, K | 1 |
| Seo, T | 1 |
| Suyama, K | 1 |
| Onaka, H | 1 |
| Ono, T | 1 |
| Ueda, S | 1 |
| Matsuo, T | 1 |
| Hirohata, S | 1 |
| Shinohara, S | 1 |
| Inoue, T | 1 |
| Miyamoto, T | 1 |
| Lipsky, PE | 1 |
| Taneichi, K | 1 |
| Watanabe, I | 1 |
| Sakai, I | 1 |
| Shibaki, H | 1 |
2 reviews available for lobenzarit and Rheumatoid Arthritis
| Article | Year |
|---|---|
Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diabetes Insipidus, Nephrogen | 1996 |
[Drug-induced renal disorders in patients with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; | 1996 |
3 trials available for lobenzarit and Rheumatoid Arthritis
| Article | Year |
|---|---|
A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Blood Sedimentation; Clinical Trials as Topic; Double-Blind Method; Drug Ther | 1984 |
[A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirh | 1995 |
[A double blind comparative study between salazosulfapyridine enteric coated tablets (PJ-306) and lobenzarit disodium (CCA) in rheumatoid arthritis].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blin | 1991 |
7 other studies available for lobenzarit and Rheumatoid Arthritis
| Article | Year |
|---|---|
Depressed natural killer activity in rheumatoid arthritis and its in vitro augmentation with interferon and N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), an anti-arthritis agent.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cytotoxicity, Immunologic; Female; Humans; Interferons; Killer C | 1981 |
The effects of the antirheumatic agents N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium (CCA) and D-penicillamine on the NK and ADCC activities and interferon production of lymphocytes.
Topics: Antibody-Dependent Cell Cytotoxicity; Arthritis, Rheumatoid; Humans; In Vitro Techniques; Interferon | 1984 |
[Effects of CCA on abnormalities of T-lymphocytes in patients with rheumatoid arthritis].
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Humans; Leukocyte Count; ortho-Aminobenzoates; T-Lymp | 1984 |
[Lobenzarit disodium (CCA)--induced diabetes insipidus in a patient with rheumatoid arthritis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diabetes Insipidus; Female; H | 1992 |
[Recurrent hyperkalemia in the course of rheumatoid arthritis--a case report].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; F | 1991 |
Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; B-Lymphocytes; Cell Cycle; Cells, Cu | 1992 |
[Association of immunomodulators and HLA antigens in rheumatoid arthritis].
Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Rheumatoid; Auranofin; Female; HLA Antigens; Humans; | 1989 |